LUKÁŠOVÁ, Emilie, Zdeněk KOŘÍSTEK, Martin FALK, Stanislav KOZUBEK, Sergei GRIGORYEV, Michal KOZUBEK, Vladan ONDŘEJ and Iva KROUPOVÁ. Methylation of histones in myeloid leukemias as a potential marker of granulocyte abnormalities. Journal of Leukocyte Biology. New York: Society for Leukocyte Biology, 2005, vol. 77, No 1, p. 100-111. ISSN 0741-5400.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Methylation of histones in myeloid leukemias as a potential marker of granulocyte abnormalities
Name in Czech Metylace histonů u myeloidních leukémií jako potenciální znak abnormality granulocytů
Authors LUKÁŠOVÁ, Emilie (203 Czech Republic), Zdeněk KOŘÍSTEK (203 Czech Republic, belonging to the institution), Martin FALK (203 Czech Republic), Stanislav KOZUBEK (203 Czech Republic), Sergei GRIGORYEV (643 Russian Federation), Michal KOZUBEK (203 Czech Republic, guarantor, belonging to the institution), Vladan ONDŘEJ (203 Czech Republic) and Iva KROUPOVÁ (203 Czech Republic).
Edition Journal of Leukocyte Biology, New York, Society for Leukocyte Biology, 2005, 0741-5400.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 4.627
RIV identification code RIV/00216224:14330/05:00012357
Organization unit Faculty of Informatics
UT WoS 000227390800013
Keywords in English human granulocytes differentiation; chromatin condensation; heterochromatin; HP1 proteins
Tags chromatin condensation, heterochromatin, HP1 proteins, human granulocytes differentiation, impacted journals+books
Tags International impact, Reviewed
Changed by Changed by: doc. RNDr. Martin Falk, Ph.D., učo 9835. Changed: 24/8/2012 13:29.
Abstract
We show that common heterochromatin antigenic protein markers [HP1alpha, -betta, -gamma and mono-, di-, and trimethylated histone H3 lysine 9 (H3K9)], although present in human blood progenitor CD34+ cells, differentiated lymphocytes, and monocytes, are absent in neutrophil granulocytes and to large extent, in eosinophils. Monomethylated and in particular, dimethylated H3K9 are present to variable degrees in the granulocytes of chronic myeloid leukemia (CML) patients, without being accompanied by HP1 proteins. In patients with an acute phase of CML and in acute myeloid leukemia patients, strong methylation of H3K9 and all isoforms of HP1 are detected. In chronic forms of CML, no strong correlations among the level of histone methylation, disease progression, and modality of treatment were observed. Histone methylation was found even in "cured" patients without Philadelphia chromosome (Ph) resulting from +(9;22)(q34;q11) BCR/ABL translocation, suggesting an incomplete process of developmentally regulated chromatin remodeling in the granulocytes of these patients. Similarly, reprogramming of leukemia HL-60 cells to terminal differentiation by retinoic acid does not eliminate H3K9 methylation and the presence of HP1 isoforms from differentiated granulocytes. Thus, our study shows for the first time that histone H3 methylation may be changed dramatically during normal cell differentiation. The residual histone H3 methylation in myeloid leukemia cells suggests an incomplete chromatin condensation that may be linked to the leukemia cell proliferation and may be important for the prognosis of disease treatment and relapse.
Abstract (in Czech)
Metylace histonů u myeloidních leukémií jako potenciální znak abnormality granulocytů.
Links
NC6987, research and development projectName: Epigeneticky kontrolované změny exprese genů u nádorových onemocnění
Investor: Ministry of Health of the CR, Epigenetic control of gene expression in malignant diseases
PrintDisplayed: 23/7/2024 00:50